Mirtazapine
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
42291-494 -
Package NDC
42291-494-30 -
Package NDC
42291-494-90 -
Application number
ANDA076541 -
SPL ID
3f7cebc7-2ea8-12e2-e063-6394a90abdc6 -
SPL set ID
e5478a6a-a29a-9f61-e053-2995a90a11d0 -
UNII
A051Q2099Q -
RxCUI
476809
What the source publishes
- Labeler
- AvKARE
- Active ingredients
- Mirtazapine
- Form
- TABLET
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Mirtazapine",
"splId": "3f7cebc7-2ea8-12e2-e063-6394a90abdc6",
"labels": [
{
"setId": "e5478a6a-a29a-9f61-e053-2995a90a11d0",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e5478a6a-a29a-9f61-e053-2995a90a11d0",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e5478a6a-a29a-9f61-e053-2995a90a11d0"
}
],
"routes": [
"ORAL"
],
"labeler": "AvKARE",
"finished": true,
"packaging": [
{
"sample": false,
"description": "30 TABLET in 1 BOTTLE (42291-494-30)",
"package_ndc": "42291-494-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20220802"
},
{
"sample": false,
"description": "90 TABLET in 1 BOTTLE (42291-494-90)",
"package_ndc": "42291-494-90",
"identifierStatus": "well-formed",
"marketing_start_date": "20250923"
}
],
"productId": "42291-494_3f7cebc7-2ea8-12e2-e063-6394a90abdc6",
"useDomain": "unknown",
"dosageForm": "TABLET",
"productNdc": "42291-494",
"deaSchedule": null,
"genericName": "Mirtazapine",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "MIRTAZAPINE",
"strength": "7.5 mg/1"
}
],
"applicationNumber": "ANDA076541",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20220802",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"upc": [
"0342291494909"
],
"unii": [
"A051Q2099Q"
],
"rxcui": [
"476809"
],
"spl_set_id": [
"e5478a6a-a29a-9f61-e053-2995a90a11d0"
],
"manufacturer_name": [
"AvKARE"
]
},
"listingExpirationDate": "20261231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:42291-494_3f7cebc7-2ea8-12e2-e063-6394a90abdc6"